Advanced Micro Devices is setting up for a robust rebound, which will likely start with the Q1 earnings release and gain momentum as the year progresses.
AbbVie is well-positioned for industry-leading growth, as Skyrizi and Rinvoq sales outperform, driving system-wide growth alongside a diversified portfolio.
Fundamentally sound dividend payers like Snap-on, Whirlpool, Verizon, and Cintas sold off along with the broad market and offer value to investors in Q2.
NVIDIA analysts trimmed targets and reduced ratings in early April, setting the market up to rebound strongly in late Q2 with the next earnings release.
Fastenal's dividend distribution and distribution growth are safe and reliable for 2025 and 2026. The company is working to mitigate tariffs and executing well.
The S&P 500 will remain under selling pressure until tariff cloudiness is replaced with certainties; the risk for the market is a cycle of guidance reduction.
Dividends from investments like REITs and infrastructure stocks have higher-than-average yields and can enhance portfolio return while reducing volatility.
NVIDIA's stock price correction has opened up a deep value, but there is a risk of buying in too early. This stock could continue to fall until headwinds ease.
Williams-Sonoma, FedEx, and Advanced Micro Devices are at rock-bottom and ready to stage rebounds that could begin in Q2 with the Q1 earnings releases. W
Lululemon's solid quarter was overshadowed by weak guidance; guidance is for growth on the top and bottom lines sufficient to sustain the capital return.